Janina Markowska

2.0k total citations
134 papers, 1.3k citations indexed

About

Janina Markowska is a scholar working on Reproductive Medicine, Oncology and Epidemiology. According to data from OpenAlex, Janina Markowska has authored 134 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Reproductive Medicine, 28 papers in Oncology and 26 papers in Epidemiology. Recurrent topics in Janina Markowska's work include Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (19 papers) and Cervical Cancer and HPV Research (18 papers). Janina Markowska is often cited by papers focused on Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (19 papers) and Cervical Cancer and HPV Research (18 papers). Janina Markowska collaborates with scholars based in Poland, Germany and Italy. Janina Markowska's co-authors include Anna Markowska, Adam Huczyński, Michał Antoszczak, Stefan Sajdak, Krzysztof Szyfter, Maciej Kujawski, PAWEŁ JAŁOSZYŃSKI, Radosław Mądry, Zbigniew Kojs and A Harłozińska and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of the New York Academy of Sciences and British Journal of Cancer.

In The Last Decade

Janina Markowska

126 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janina Markowska Poland 19 521 370 323 246 172 134 1.3k
Ansgar Brüning Germany 24 793 1.5× 326 0.9× 155 0.5× 148 0.6× 124 0.7× 57 1.6k
S. Hauptmann Germany 20 668 1.3× 346 0.9× 130 0.4× 297 1.2× 57 0.3× 50 1.5k
Jim Jinn‐Chyuan Sheu Taiwan 30 1.2k 2.3× 355 1.0× 243 0.8× 467 1.9× 100 0.6× 93 2.2k
Po-Hui Wang Taiwan 19 518 1.0× 170 0.5× 103 0.3× 260 1.1× 117 0.7× 84 1.3k
Tianmin Xu China 27 1.3k 2.5× 370 1.0× 181 0.6× 623 2.5× 153 0.9× 96 2.6k
Shinji Iwasaki Japan 22 530 1.0× 353 1.0× 155 0.5× 92 0.4× 94 0.5× 80 1.9k
Jing Yu China 20 452 0.9× 321 0.9× 79 0.2× 255 1.0× 56 0.3× 64 1.1k
T. Frank United States 17 670 1.3× 279 0.8× 207 0.6× 347 1.4× 76 0.4× 28 1.7k
Kimio Mizuno Japan 19 413 0.8× 127 0.3× 307 1.0× 61 0.2× 155 0.9× 50 1.1k

Countries citing papers authored by Janina Markowska

Since Specialization
Citations

This map shows the geographic impact of Janina Markowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janina Markowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janina Markowska more than expected).

Fields of papers citing papers by Janina Markowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janina Markowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janina Markowska. The network helps show where Janina Markowska may publish in the future.

Co-authorship network of co-authors of Janina Markowska

This figure shows the co-authorship network connecting the top 25 collaborators of Janina Markowska. A scholar is included among the top collaborators of Janina Markowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janina Markowska. Janina Markowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markowska, Anna, Zbigniew Kojs, Michał Antoszczak, Janina Markowska, & Adam Huczyński. (2025). Epigallocatechin Gallate as a Potential Therapeutic Agent in Endometriosis: A Narrative Review. Nutrients. 17(13). 2068–2068.
2.
Markowska, Anna, Michał Antoszczak, Janina Markowska, & Adam Huczyński. (2023). Role of Hyaluronic Acid in Selected Malignant Neoplasms in Women. Biomedicines. 11(2). 304–304. 11 indexed citations
3.
Markowska, Anna, Michał Antoszczak, Janina Markowska, & Adam Huczyński. (2023). The Role of Selected Dietary Factors in the Development and Course of Endometriosis. Nutrients. 15(12). 2773–2773. 16 indexed citations
4.
Markowska, Anna, Michał Antoszczak, Janina Markowska, & Adam Huczyński. (2022). Role of Vitamin C in Selected Malignant Neoplasms in Women. Nutrients. 14(4). 882–882. 22 indexed citations
5.
Markowska, Anna, Michał Antoszczak, Janina Markowska, & Adam Huczyński. (2022). Role of Vitamin K in Selected Malignant Neoplasms in Women. Nutrients. 14(16). 3401–3401. 21 indexed citations
6.
Markowska, Anna, Michał Antoszczak, Zbigniew Kojs, et al.. (2020). Role of vitamin D3 in selected malignant neoplasms. Nutrition. 79-80. 110964–110964. 24 indexed citations
7.
Markowska, Anna, et al.. (2019). Hypoxia and its importance in the course of gynaecological cancers. European Journal of Gynaecological Oncology. 40(5). 711–713. 2 indexed citations
8.
Markowska, Anna, Stefan Sajdak, Janina Markowska, & Adam Huczyński. (2017). Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer. European Journal of Medicinal Chemistry. 142. 87–94. 65 indexed citations
9.
Huczyński, Adam, et al.. (2016). Salinomycyna – przełom w leczeniu raka jajnika?. 14(3). 156–161. 1 indexed citations
10.
Basta, Antoni, Mariusz Bidziński, Andrzej Bieńkiewicz, et al.. (2015). Rekomendacje Polskiego Towarzystwa Ginekologii Onkologicznej dotyczące diagnostyki i leczenia raka jajnika Wersja 2015.1. Via Medica Journals. 1(2). 83–93. 1 indexed citations
11.
Basta, Antoni, Mariusz Bidziński, Andrzej Bieńkiewicz, et al.. (2015). Recommendation of the Polish Society of Oncological Gynaecology on the diagnosis and treatment of epithelial ovarian cancer. Oncology in Clinical Practice. 11(5). 233–243. 10 indexed citations
12.
Herzog, Thomas J., Giovanni Scambia, Byoung‐Gie Kim, et al.. (2013). A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma. Gynecologic Oncology. 130(1). 25–30. 69 indexed citations
13.
Markowska, Janina, et al.. (2011). Nosicielstwo mutacji w eksonie 6 genu NBS1 a ryzyko zachorowania na mięśniaki macicy. Nowotwory Journal of Oncology. 61(2). 109–109. 1 indexed citations
14.
Markowska, Janina, et al.. (2008). Thromboembolic complications in cancer. Contemporary Oncology/Współczesna Onkologia. 12(2). 56–60. 2 indexed citations
15.
Markowska, Janina. (2007). Tumor makers in cervical cancer. Ginekologia Polska. 78(9). 1 indexed citations
16.
Tomczak, Piotr, et al.. (2005). Oncology and infertility: selected issues. Part I. What causes fertility disorders?. Contemporary Oncology/Współczesna Onkologia. 9(1). 26–29. 2 indexed citations
17.
Tomczak, Piotr, et al.. (2005). Oncology and infertility: selected issues. Part II. Preservation of the reproductive function. Contemporary Oncology/Współczesna Onkologia. 9(2). 65–68. 1 indexed citations
18.
Litwiniuk, Maria, et al.. (2004). Brain metastases in patients with breast cancer. Contemporary Oncology/Współczesna Onkologia. 8(8). 390–394.
19.
Bar, Julia, et al.. (2001). Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias.. PubMed. 21(2A). 1001–6. 15 indexed citations
20.
Markowska, Janina, et al.. (1994). Retrospective appraisal of intensity of skin postradiation reactions in breast cancer patients treated with telegammatherapy.. PubMed. 15(5). 372–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026